Editor's Correspondence
June 22, 1998

Sublingual Nifedipine–Induced Anaphylaxis

Author Affiliations

Copyright 1998 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1998

Arch Intern Med. 1998;158(12):1378-1379. doi:

Nifedipine therapy administered sublingually or swallowed during treatment of hypertensive emergencies and pseudoemergencies has been widely used in the last decade. Severe adverse effects including symptomatic hypotension,1 stroke,2 ST-segment depression, ventricular fibrillation,3 and myocardial infarction have been reported.4 We describe herein a patient who developed anaphylaxis after receiving sublingual nifedipine for pseudoemergency hypertensive treatment.

First Page Preview View Large
First page PDF preview
First page PDF preview